Harvard University has granted a worldwide exclusive license to Sherlock Biosciences Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
An innovative clinical trial attempts to stave off dementia in socially isolated seniors through regular half-hour conversations with trained conversationalists through online video chat. Previous pilot studies showed promising results, clearing the way for the National Institute on Aging to fund the full-scale clinical trial that's now underway.
The Endocrine Society applauded the European Parliament's release of a report demonstrating that endocrine-disrupting chemicals (EDCs) pose a serious threat to the health of current and future generations and illustrating the need for additional action by policymakers in the EU to address this issue.
To educate and inspire people about how to farm and garden sustainably in the Northeast, three student-led permaculture gardens at the University of Massachusetts Amherst are now featured in vivid and interactive, 360-degree splendor on the USDA's Climate Hubs website.
3D-printing can be used to produce structures, even in the nanoscale. Depending on the 'ink' various functions seem possible: from hybrid optical chips to bioscaffolds for cell tissue. Within the Cluster of Excellence '3D Matter Made to Order,' researchers of KIT and the University Heidelberg plan to raise additive manufacture to the next level. The goal is to develop new technologies for flexible, digital printing of structures from the molecular to the macroscopic scale.
A new sensor system developed in Saarbrücken, Germany, can not only carefully control drying processes in industrial ovens, but can deliver reliable air humidity measurements even at high temperatures and in the presence of other background vapors. Professor Andreas Schütze, project manager Tilman Sauerwald and their research team at Saarland University have developed with partner companies a sensor system that precisely monitors industrial drying, baking and cooking processes.
The FDA has approved brexanolone, an analog of the endogenous human hormone allopregnanolone and the first drug specifically designed to treat postpartum depression. FDA approval represents the final phase of a bench-to-bedside journey for this drug -- a journey that began in the NIMH Intramural Research Program (IRP). Want to learn more about this story? NIMH experts are available to provide information on postpartum depression and the importance of, and the science underlying, brexanolone.
Japan's contribution to high-quality scientific research fell by 19.9 percent between January 2012 and October 2018 according to the Nature Index. But efforts to increase international collaboration, seen as one way to address this trend, are paying off. Since 2014, the proportion of articles from journals tracked by the Index with international co-authors originating from Japanese institutions has increased from 46 to 56 percent.
The US Food and Drug Administration (FDA) approved ZULRESSO (brexanolone) injection today for the treatment of postpartum depression (PPD) after reviewing the results from three multicenter, randomized, double-blind, parallel-group, placebo-controlled trials in the US.
Mary Ann Liebert Inc. publishers announces the launch of Death Research: The Last Frontier, a bold new peer-reviewed journal dedicated to the science, technology, applications, and physical aspects of death and postmortem research.